
NASDAQ:CSII • US1416191062
ChartMill assigns a Buy % Consensus number of 48% to CSII. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-12-21 | Barclays | Initiate | Equal-Weight |
| 2022-05-05 | SVB Leerink | Maintains | Outperform |
| 2022-02-04 | SVB Leerink | Maintains | Outperform |
| 2021-11-17 | Needham | Downgrade | Buy -> Hold |
| 2021-11-10 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-11-10 | SVB Leerink | Maintains | Outperform |
| 2021-09-23 | Needham | Maintains | Buy |
| 2021-05-25 | Barclays | Initiate | Equal-Weight |
12 analysts have analysed CSII and the average price target is 17.75 USD. This implies a price decrease of -11.26% is expected in the next year compared to the current price of 20.
The consensus rating for CARDIOVASCULAR SYSTEMS INC (CSII) is 48.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering CARDIOVASCULAR SYSTEMS INC (CSII) is 12.